G39V (p.Gly39Val) variant of NLRP1 (Q9C000)
G39V (p.Gly39Val) in NLRP1 (Q9C000) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.06 / 1. The record also includes population frequency data.
G39V (p.Gly39Val) variant details
- p.Gly39Val
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.0568
- CADD 0.73
- PolyPhen-2 0.07
- SIFT 0.09
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available